SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Metropolis Healthcare acquires Core Diagnostics

24 Mar 2025 Evaluate

Metropolis Healthcare has completed the acquisition of Core Diagnostics from Core Diagnostics (Mauritius). The company’s board has approved the allotment of equity shares of the company on a preferential basis to Core Diagnostics (Mauritius) as part of the agreed purchase consideration, while the remaining balance of the purchase consideration has been remitted in cash to Core Diagnostics (Mauritius), with Rs 5 crore withheld as deferred consideration to be paid subject to closing adjustments by the parties. Core Diagnostics (Mauritius) has transferred its 100% stake in Core Diagnostics to the company, and necessary confirmations have been received from the respective Depository Participants as part of this process. With this, Core Diagnostics becomes a wholly owned subsidiary of the company.

Earlier, the company’s board had approved the acquisition of the 100% stake in Core Diagnostics from Core Diagnostics (Mauritius). This strategic acquisition will enhance company’s advanced cancer testing capabilities and strengthen its footprint in Northern and Eastern India. By leveraging Core Diagnostics’ strong relationships with leading cancer specialists and hospitals in these regions, the company aims to expand its market reach and specialized testing offerings. The acquisition also provides an opportunity to offer Metropolis’ broad range of diagnostic services to Core Diagnostics’ network, while bringing Core Diagnostics’ advanced cancer testing to its existing customer base. Moreover, the integration is expected to drive synergies through optimized laboratory operations, improved efficiencies, and cost reductions, further solidifying Metropolis’ leadership in the diagnostics industry.

Metropolis Healthcare is engaged in the business of providing pathology and related healthcare services. 


Metropolis Health. Share Price

470.80 -1.75 (-0.37%)
17-Apr-2026 16:59 View Price Chart
Peers

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×